- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Evaluation of effectiveness in terms of survival without metastases to 10 years, of adjuvant hormonal treatment with leuprorelin acetate (Eligard® 45 mg) for 24 months after radical prostatectomy in patients with high risk of recurrence.
Critère d'inclusion
- PROSTATIC ADENOCARCINOMA WITH HIGH RISK OF RECURRENCE